ID
45572
Descrição
Principal Investigator: Glen Weiss, MD, Translational Genomics Research Institute, Phoenix, AZ, USA MeSH: Carcinoma https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000657 In this study, we used NGS to identify somatic events in advanced stage cancer patients to demonstrate the feasibility for using this approach to improve patient treatment.
Link
Palavras-chave
Versões (1)
- 24/01/2023 24/01/2023 - Dr. Christian Niklas
Titular dos direitos
Glen Weiss, MD, Translational Genomics Research Institute, Phoenix, AZ, USA
Transferido a
24 de janeiro de 2023
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
dbGaP phs000657 NGS in Advanced Cancers
Subject ID, consent group, and type of research where were involved participants of the "A Pilot Study Using Next Generation Sequencing in Advanced Cancers: Feasibility and Challenges" project.
- StudyEvent: SEV1
- Subject ID, consent group, and type of research where were involved participants of the "A Pilot Study Using Next Generation Sequencing in Advanced Cancers: Feasibility and Challenges" project.
- Subject ID, sample ID, and sample use variables obtained from participants of the "A Pilot Study Using Next Generation Sequencing in Advanced Cancers: Feasibility and Challenges" project.
- Subject ID, age, sex, and race of participants of the "A Pilot Study Using Next Generation Sequencing in Advanced Cancers: Feasibility and Challenges" project.
- Sample ID, body site where sample was collected, analyte type, tumor status of sample, histological type of sample, primary tumor, metastasis, or transformed cell line, and primary tumor location of participants of the "A Pilot Study Using Next Generation Sequencing in Advanced Cancers: Feasibility and Challenges" project.
Similar models
Subject ID, consent group, and type of research where were involved participants of the "A Pilot Study Using Next Generation Sequencing in Advanced Cancers: Feasibility and Challenges" project.
- StudyEvent: SEV1
- Subject ID, consent group, and type of research where were involved participants of the "A Pilot Study Using Next Generation Sequencing in Advanced Cancers: Feasibility and Challenges" project.
- Subject ID, sample ID, and sample use variables obtained from participants of the "A Pilot Study Using Next Generation Sequencing in Advanced Cancers: Feasibility and Challenges" project.
- Subject ID, age, sex, and race of participants of the "A Pilot Study Using Next Generation Sequencing in Advanced Cancers: Feasibility and Challenges" project.
- Sample ID, body site where sample was collected, analyte type, tumor status of sample, histological type of sample, primary tumor, metastasis, or transformed cell line, and primary tumor location of participants of the "A Pilot Study Using Next Generation Sequencing in Advanced Cancers: Feasibility and Challenges" project.
C0441833 (UMLS CUI [1,2])
C0242481 (UMLS CUI [1,2])
C1516606 (UMLS CUI [1,2])